Compass Therapeutics, Inc. (CMPX)
(Real Time Quote from BATS)
$1.05 USD
-0.01 (-0.94%)
Updated Jun 26, 2024 02:40 PM ET
3-Hold of 5 3
C Value F Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Compass Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -42.49 | -39.23 | -82.18 | -29.50 | -34.74 |
Depreciation/Amortization & Depletion | -1.34 | 1.10 | 1.62 | 2.40 | 2.12 |
Net Change from Assets/Liabilities | -2.91 | -1.26 | 6.24 | -4.65 | -0.25 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.12 | 5.26 | 54.65 | 4.94 | 1.14 |
Net Cash From Operating Activities | -40.62 | -34.13 | -19.67 | -26.80 | -31.74 |
Property & Equipment | -0.03 | -0.04 | -1.45 | 0.04 | -0.47 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -0.32 | 0.00 | 0.00 |
Investments | 27.00 | -151.16 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 26.97 | -151.20 | -1.77 | 0.04 | -0.47 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.09 | 75.76 | 127.99 | 54.16 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -9.38 | -5.63 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 2.94 | 75.76 | 118.61 | 48.54 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -10.72 | -109.57 | 97.18 | 21.77 | -32.21 |
Cash at Beginning of Period | 34.95 | 144.51 | 47.34 | 25.57 | 57.77 |
Cash at End of Period | 24.23 | 34.95 | 144.51 | 47.34 | 25.57 |
Diluted Net EPS | -0.33 | -0.37 | -1.31 | -0.96 | NA |
Fiscal Year End for Compass Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.79 | -42.49 | -29.08 | -19.12 | -7.84 |
Depreciation/Amortization & Depletion | 0.09 | -1.34 | -0.99 | -0.67 | -0.11 |
Net Change from Assets/Liabilities | -5.19 | -2.91 | -2.71 | -5.45 | -5.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.00 | 6.12 | 4.52 | 2.90 | 1.27 |
Net Cash From Operating Activities | -13.89 | -40.62 | -28.26 | -22.34 | -12.23 |
Property & Equipment | 0.00 | -0.03 | -0.02 | -0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -4.10 | 27.00 | 20.67 | 3.61 | 4.27 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.10 | 26.97 | 20.65 | 3.60 | 4.27 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 17.57 | 3.09 | 3.09 | 3.07 | 0.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.14 | -0.16 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 17.43 | 2.94 | 3.09 | 3.07 | 0.04 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.55 | -10.72 | -4.52 | -15.67 | -7.92 |
Cash at Beginning of Period | 24.23 | 34.95 | 34.95 | 34.95 | 34.95 |
Cash at End of Period | 23.67 | 24.23 | 30.43 | 19.28 | 27.03 |
Diluted Net EPS | -0.08 | -0.10 | -0.08 | -0.09 | -0.06 |